LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Search

Bio-Techne Corp

Closed

Sector Healthcare

80.52 2.4

Overview

Share price change

24h

Current

Min

78.49

Max

80.92

Key metrics

By Trading Economics

Income

22M

49M

Sales

303B

303B

P/E

Sector Avg

50.64

79.786

EPS

0.48

Profit margin

0.016

EBITDA

8.2M

92M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+4.23 upside

Dividends

By Dow Jones

Next Earnings

7 Aug 2024

Next Dividend date

30 Aug 2024

Next Ex Dividend date

15 Aug 2024

Market Stats

By TradingEconomics

Market Cap

1B

12B

Previous open

78.12

Previous close

80.52

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Bio-Techne Corp Chart

Related News

26 Jul 2024, 22:06 UTC

Major Market Movers

vTv Therapeutics Shares Tumble After FDA Pauses Diabetes-Treatment Study

26 Jul 2024, 19:26 UTC

Earnings

Trending: 3M Shares Surge On Earnings

26 Jul 2024, 17:40 UTC

Earnings

Merck KGaA FY24 Outlook Improves After Strong Second Quarter

26 Jul 2024, 17:21 UTC

Major Market Movers

Aon Shares Rise Following Better-Than-Expected 2Q Results

26 Jul 2024, 22:40 UTC

Acquisitions, Mergers, Takeovers

Burger King Parent Company and More Stocks See Action From Activist Investors -- Barrons.com

26 Jul 2024, 21:27 UTC

Market Talk

Consumers Are Skipping Starbucks' Half-Priced Drinks -- Market Talk

26 Jul 2024, 20:54 UTC

Earnings

3M Stock Had Its Best Day Ever. The New CEO Started With a Bang. -- Barrons.com

26 Jul 2024, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

26 Jul 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 Jul 2024, 20:50 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

26 Jul 2024, 20:50 UTC

Top News

Dow Industrials Jump to Cap Volatile Week -- WSJ

26 Jul 2024, 20:27 UTC

Acquisitions, Mergers, Takeovers

Blackstone Real Estate, MRP Group Announce Extension of 100% Cash Tender Offer for Terrafina

26 Jul 2024, 20:16 UTC

Earnings

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 Jul 2024, 19:28 UTC

Market Talk

U.S. Natural Gas Futures Fall for Second Straight Week -- Market Talk

26 Jul 2024, 19:15 UTC

Market Talk

Oil Futures Close Lower for a Third Straight Week -- Market Talk

26 Jul 2024, 19:00 UTC

Market Talk

Nike Must Restore Exclusivity to Jumpstart Footwear Brand -- Market Talk

26 Jul 2024, 18:29 UTC

Market Talk

Gold Shares Attempt To Reverse Losses -- Market Talk

26 Jul 2024, 17:36 UTC

Market Talk

U.S. Oil Rig Count Rises By Five To 482 -- Market Talk

26 Jul 2024, 16:57 UTC

Earnings

Merck KGaA to Post Full 2Q Figures as Scheduled on Aug 1

26 Jul 2024, 16:55 UTC

Earnings

Merck KGaA Sees 2024 EBITDA Before One-Time Items of Approx. EUR5.8B to EUR6.4B

26 Jul 2024, 16:54 UTC

Earnings

Merck KGaA Sees 2024 Net Sales of Approx. EUR20.7B to EUR22.1B

26 Jul 2024, 16:54 UTC

Earnings

Merck KGaA: Performance of Life Science Is Within Expectations

26 Jul 2024, 16:54 UTC

Earnings

Merck KGaA: Main Driver Is Very Strong Oper Performance of Healthcare, Electronics Compared to Consensus

26 Jul 2024, 16:53 UTC

Earnings

Merck KGaA 2Q EBITDA Before One-Time Items EUR1.51B

26 Jul 2024, 16:52 UTC

Earnings

Merck KGaA 2Q Net Sales EUR5.35B

26 Jul 2024, 16:51 UTC

Earnings

Intel's AI Chip Story 'Feels Mostly MIA,' Says Analyst -- Barrons.com

26 Jul 2024, 16:51 UTC

Earnings

Merck KGaA Raised Guidance for Fiscal 2024

26 Jul 2024, 16:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

26 Jul 2024, 16:20 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

26 Jul 2024, 16:20 UTC

Market Talk
Earnings

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Bio-Techne Corp Forecast

Price Target

By TipRanks

4.23% upside

12 Months Forecast

Average 82 USD  4.23%

High 95 USD

Low 65 USD

Based on 8 Wall Street analysts offering 12 month price targets forBio-Techne Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

77.77 / 80.515Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Neutral Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bio-Techne Corp

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.